Shaunak Parikh joined EW in 2013 as Associate, was promoted to Vice President in 2014, and to Principal in 2017.
Mr. Parikh has played a key role on the Board of Directors in EW growth equity portfolio companies Bioventus, Encore Dermatology, Prolacta Bioscience, and TissueTech.
Prior to joining EW, Mr. Parikh worked at Health Evolution Partners, a private equity firm focused on healthcare growth equity investments and buyouts. Previously, he worked in the investment banking group at Citigroup, where he focused on mergers and acquisitions primarily in the medical device, specialty pharmaceutical and medical technology sectors.
Mr. Parikh earned his Master of Business Administration degree from The Wharton School at the University of Pennsylvania and graduated Phi Beta Kappa and with Honors from the University of California, Los Angeles with a Bachelor of Sciences degree in Microbiology, Immunology and Molecular Genetics and a Bachelor of Arts degree in Economics.